Medicines and Falls – what does the audience participation indicate about future learning needs?

Introduction: On behalf of National Falls Prevention Coordination Group, we were tasked with creating a user friendly guide on Medicines and Falls. We delivered two sessions on this topic one at British Geriatric Society Conference in November 2023 and another to Specialist Pharmacy Service audience in January 2024.

Method: Audience participation was used in both sessions as part of the discussion on “What do you consider important when completing a medication review in a person who is at risk of falls?” and “Which group of medicines do you prioritise for deprescribing discussion in patients at risk of falls?”. The results from slido contribution were analysed for trends and future learning needs.

Results: In the SPS audience, greater level of importance was imparted on individual drug classes when considering question of “what is important when reviewing a person at risk of falls” with anticholinergic burden being quoted most frequently and patient goals being second. Reducing risk and patient goals were the two items which the BGS audience prioritised. In terms of groups of medication to prioritise for deprescribing discussion, SPS audience once again chose anticholinergic medication followed by sedatives while BGS categorised antihypertensives and diuretics most commonly.

Conclusion(s): When completing falls medication reviews, medication groups were most commonly thought as important by pharmacy-focused audience, with patient goals the second most important aspect whilst the BGS audience prioritised reducing risk and patient goals. There should be greater emphasis on managing risk as part of teaching offerings to teams where therapeutics is the core focus. In terms of groups of medications to deprescribe, better guidance around reviewing antihypertensives and diuretics would facilitate more effective falls medication reviews. The difference observed between prioritising anticholinergic burden reduction indicates that general geriatric audience would benefit from further awareness raising of their contribution to falls risk.